Houston Cyclotron Partners - Cyclotope Radiopharmacy - Ownership and Business Overview

Life ScienceCompany

Houston Cyclotron Partners - Cyclotope Radiopharmacy Ownership

Who owns Houston Cyclotron Partners - Cyclotope Radiopharmacy?

Houston Cyclotron Partners - Cyclotope Radiopharmacy is owned by Sofie Biosciences. It was acquired on June 17, 2019.

Houston Cyclotron Partners - Cyclotope Radiopharmacy Business Overview

Where is Houston Cyclotron Partners - Cyclotope Radiopharmacy headquartered?

Houston Cyclotron Partners - Cyclotope Radiopharmacy is headquartered in Houston, Texas.

What sector is Houston Cyclotron Partners - Cyclotope Radiopharmacy in?

Houston Cyclotron Partners - Cyclotope Radiopharmacy is a life science company.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 252 acquisitions of life science companies in 2019, including 45 acquisitions by private equity firms, and 207 by strategics.

Houston Cyclotron Partners LP - Cyclotope Radiopharmacy

Houston, Texas 77054
United States,

Houston Cyclotron Partners LP - Cyclotope Radiopharmacy operate 17 radiopharmacies throughout the US, with plans to expand into five additional markets in the next 24 months. The company serves over 400,000 patients annually at 700 clinical practices and supports R&D and contract manufacturing for both pharma partnerships and SOFIE's own proprietary drug development efforts.


 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.